<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2012102311228N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2013-01-03</date_registration>
      <primary_sponsor>Vice Chancellor for research, Kashan University of Medical Sciences</primary_sponsor>
      <public_title>Effect of preoperative percutaneous electrical nerve stimulation on severity of postoperative pain</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of preoperative percutaneous electrical nerve stimulation on intensity of pain surgery in patient under inguinal herniorrhaphy in case and control groups</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2012-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>66</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/11526</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Pain.</hc_freetext>
      <i_freetext>Intervention 1: In the case group one hour before the surgery TENS device EV-906 model made in Taiwan is connected to the incision site by the interviewer number 1. Sensory intensity is activated in the range of 9 to 18 mA in the TENS device. Frequency and wavelength in each channel is increased until the patient is able to feel tingling without any unpleasant sensation. The prediction of postoperative pain is done by the interviewer number 2 using the Face Scale&#13;
Test. In the operating room 2 micrograms per kilogram of fentanyl is prescribed as premedication. Anesthesia is induced with 6 milligrams per kilogram of Nesdonal. During the operation, two micrograms per kilogram per hour fentanyl is prescribed as analgesic. After the surgery the patient will be monitored in the recovery room for 2 hours. During this time, if the patient's pain score based on Face-scale Test is over 4 IV infusion of 25 mg pethidine will be administered. After installation of the PCA pump which contains 200 mg pethedine dissolved in 100 cc normal saline the patient is transferred to the ward. If the button is pressed by the patient the amount of 1 cc of pethidine and normal saline solution is simultaneously injected.&#13;
This dose can only be repeated for four times in an hour. If the patient's complaint of pain persists 100 mg diclofenac suppository is used. Questionnaire (containing questions about severity of pain, nausea, vomiting, headache and dizziness, and the amount of analgesic consumption) at 4, 6, 12 and 24 hours after the surgery is completed by asking the patient and evaluation of the PCA pump, and the patient's file. Intervention 2: In the control group one hour before the surgery TENS device EV-906 model made in Taiwan is connected to the incision site by the interviewer number 1. The indicator light is on but the device is inactive. The prediction of postoperative pain is done by the interviewer number 2 using the Face Scale Test. In the operating room 2 micrograms per kilogram of fentanyl is prescribed as premedication. Anesthesia is induced with 6 milligrams per kilogram of Nesdonal. During the operation, two micrograms per kilogram per hour fentanyl is prescribed as analgesic. After the surgery the patient will be monitored in the recovery room for 2 hours. During this time, if the patient's pain score based on Face-scale Test is over 4 IV infusion of 25 mg pethidine will be administered. After installation of the PCA pump which contains 200 mg pethedine dissolved in 100 cc normal saline the patient is transferred to the ward. If the button is pressed by the patient the amount of 1 cc of pethidine and normal saline solution is simultaneously injected. This dose can only be repeated for four times in an hour. If the patient's complaint of pain persists 100 mg diclofenac suppository is used. Questionnaire (containing questions about severity of pain, nausea, vomiting, headache and dizziness, and the amount of analgesic consumption) at 4, 6, 12 and 24 hours after the surgery is completed by asking the patient and evaluation of the PCA pump, and the patient's file.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Monir Janzamini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>General Surgery Group, First Floor, Shahid Beheshti Hospital, Ghotbe Ravandi Blvd.</address>
        <city>Kashan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 36 1555 0026</telephone>
        <email>janzamini@kaums.ac.ir</email>
        <affiliation>Kashan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Monir Janzamini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>General Surgery Group, First Floor, Shahid Beheshti Hospital, Ghotbe Ravandi Blvd.</address>
        <city>Kashan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 36 1555 0026</telephone>
        <email>janzamini@kaums.ac.ir</email>
        <affiliation>Kashan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: Male, aged 20 to 50, suffering from inguinal hernia; Use of Liechtenstein surgical procedure; Surgery performed in the morning to avoid circadian cycle; Physical status of ASA I or II; Absence of hearing, visual or talking impairment; Lack of cognitive impairment; No exclusion criteria &#13;
Exclusion criteria: Conditions prohibiting the use of TENS, (such as pacemakers, because of the unknown effects of TENS on electrical conduction system or placing the electrode directly on open wounds); Obesity (weight more than 100 pounds above ideal weight); Recurrent, incarcerated and bilateral hernia; Skin infection or severe skin disease in the place of the electrodes; Chronic use of narcotics or antidepressant drugs</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R10.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pain localized to other parts of lower abdomen</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In the case group one hour before the surgery TENS device EV-906 model made in Taiwan is connected to the incision site by the interviewer number 1. Sensory intensity is activated in the range of 9 to 18 mA in the TENS device. Frequency and wavelength in each channel is increased until the patient is able to feel tingling without any unpleasant sensation. The prediction of postoperative pain is done by the interviewer number 2 using the Face Scale&#13;
Test. In the operating room 2 micrograms per kilogram of fentanyl is prescribed as premedication. Anesthesia is induced with 6 milligrams per kilogram of Nesdonal. During the operation, two micrograms per kilogram per hour fentanyl is prescribed as analgesic. After the surgery the patient will be monitored in the recovery room for 2 hours. During this time, if the patient's pain score based on Face-scale Test is over 4 IV infusion of 25 mg pethidine will be administered. After installation of the PCA pump which contains 200 mg pethedine dissolved in 100 cc normal saline the patient is transferred to the ward. If the button is pressed by the patient the amount of 1 cc of pethidine and normal saline solution is simultaneously injected.&#13;
This dose can only be repeated for four times in an hour. If the patient's complaint of pain persists 100 mg diclofenac suppository is used. Questionnaire (containing questions about severity of pain, nausea, vomiting, headache and dizziness, and the amount of analgesic consumption) at 4, 6, 12 and 24 hours after the surgery is completed by asking the patient and evaluation of the PCA pump, and the patient's file.</i_keyword>
      <i_keyword>In the control group one hour before the surgery TENS device EV-906 model made in Taiwan is connected to the incision site by the interviewer number 1. The indicator light is on but the device is inactive. The prediction of postoperative pain is done by the interviewer number 2 using the Face Scale Test. In the operating room 2 micrograms per kilogram of fentanyl is prescribed as premedication. Anesthesia is induced with 6 milligrams per kilogram of Nesdonal. During the operation, two micrograms per kilogram per hour fentanyl is prescribed as analgesic. After the surgery the patient will be monitored in the recovery room for 2 hours. During this time, if the patient's pain score based on Face-scale Test is over 4 IV infusion of 25 mg pethidine will be administered. After installation of the PCA pump which contains 200 mg pethedine dissolved in 100 cc normal saline the patient is transferred to the ward. If the button is pressed by the patient the amount of 1 cc of pethidine and normal saline solution is simultaneously injected. This dose can only be repeated for four times in an hour. If the patient's complaint of pain persists 100 mg diclofenac suppository is used. Questionnaire (containing questions about severity of pain, nausea, vomiting, headache and dizziness, and the amount of analgesic consumption) at 4, 6, 12 and 24 hours after the surgery is completed by asking the patient and evaluation of the PCA pump, and the patient's file.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The surgical site pain. Timepoint: 2, 4, 6, 12 and 24 hours after the surgery. Method of measurement: Using the visual analog scale method.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Vomitting. Timepoint: 2, 4, 6, 12 and 24 hours after the surgery. Method of measurement: Asking the patient.</sec_outcome>
      <sec_outcome>Nausea. Timepoint: 2, 4, 6, 12 and 24 hours after the surgery. Method of measurement: Asking the patient.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for research, Kashan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2012-11-20</approval_date>
        <contact_name>Kashan University of Medical Sciences ethics committee</contact_name>
        <contact_address>Kashan Medical Sciences complex, Ghotbe Ravandi Blvd., Vice chancellor for research Kashan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
